Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients.

Zeka F, Decock A, Van Goethem A, Vanderheyden K, Demuynck F, Lammens T, Helsmoortel HH, Vermeulen J, Noguera R, Berbegall AP, Combaret V, Schleiermacher G, Laureys G, Schramm A, Schulte JH, Rahmann S, Bienertová-Vašků J, Mazánek P, Jeison M, Ash S, Hogarty MD, Moreno-Smith M, Barbieri E, Shohet J, Berthold F, Van Maerken T, Speleman F, Fischer M, De Preter K, Mestdagh P, Vandesompele J.

JCI Insight. 2018 Dec 6;3(23). pii: 97021. doi: 10.1172/jci.insight.97021.

2.

MicroRNA Expression Analysis Using Small RNA Sequencing Discovery and RT-qPCR-Based Validation.

Van Goethem A, Mestdagh P, Van Maerken T, Vandesompele J.

Methods Mol Biol. 2017;1654:197-208. doi: 10.1007/978-1-4939-7231-9_13.

PMID:
28986791
3.

Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma.

Van Goethem A, Yigit N, Moreno-Smith M, Vasudevan SA, Barbieri E, Speleman F, Shohet J, Vandesompele J, Van Maerken T.

Oncotarget. 2017 Jul 4;8(34):57047-57057. doi: 10.18632/oncotarget.18982. eCollection 2017 Aug 22.

4.

EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research.

EV-TRACK Consortium, Van Deun J, Mestdagh P, Agostinis P, Akay Ö, Anand S, Anckaert J, Martinez ZA, Baetens T, Beghein E, Bertier L, Berx G, Boere J, Boukouris S, Bremer M, Buschmann D, Byrd JB, Casert C, Cheng L, Cmoch A, Daveloose D, De Smedt E, Demirsoy S, Depoorter V, Dhondt B, Driedonks TA, Dudek A, Elsharawy A, Floris I, Foers AD, Gärtner K, Garg AD, Geeurickx E, Gettemans J, Ghazavi F, Giebel B, Kormelink TG, Hancock G, Helsmoortel H, Hill AF, Hyenne V, Kalra H, Kim D, Kowal J, Kraemer S, Leidinger P, Leonelli C, Liang Y, Lippens L, Liu S, Lo Cicero A, Martin S, Mathivanan S, Mathiyalagan P, Matusek T, Milani G, Monguió-Tortajada M, Mus LM, Muth DC, Németh A, Nolte-'t Hoen EN, O'Driscoll L, Palmulli R, Pfaffl MW, Primdal-Bengtson B, Romano E, Rousseau Q, Sahoo S, Sampaio N, Samuel M, Scicluna B, Soen B, Steels A, Swinnen JV, Takatalo M, Thaminy S, Théry C, Tulkens J, Van Audenhove I, van der Grein S, Van Goethem A, van Herwijnen MJ, Van Niel G, Van Roy N, Van Vliet AR, Vandamme N, Vanhauwaert S, Vergauwen G, Verweij F, Wallaert A, Wauben M, Witwer KW, Zonneveld MI, De Wever O, Vandesompele J, Hendrix A.

Nat Methods. 2017 Feb 28;14(3):228-232. doi: 10.1038/nmeth.4185.

PMID:
28245209
5.

Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples.

Van Goethem A, Yigit N, Everaert C, Moreno-Smith M, Mus LM, Barbieri E, Speleman F, Mestdagh P, Shohet J, Van Maerken T, Vandesompele J.

Sci Rep. 2016 Nov 30;6:37876. doi: 10.1038/srep37876.

6.

Exploring Curved Schematization of Territorial Outlines.

van Goethem A, Meulemans W, Speckmann B, Wood J.

IEEE Trans Vis Comput Graph. 2015 Aug;21(8):889-902. doi: 10.1109/TVCG.2015.2401025.

PMID:
26357253
7.

Stenomaps: Shorthand for shapes.

van Goethem A, Reimer A, Speckmann B, Wood J.

IEEE Trans Vis Comput Graph. 2014 Dec;20(12):2053-62. doi: 10.1109/TVCG.2014.2346274.

PMID:
26356919
8.

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment.

Lambertz I, Kumps C, Claeys S, Lindner S, Beckers A, Janssens E, Carter DR, Cazes A, Cheung BB, De Mariano M, De Bondt A, De Brouwer S, Delattre O, Gibbons J, Janoueix-Lerosey I, Laureys G, Liang C, Marchall GM, Porcu M, Takita J, Trujillo DC, Van Den Wyngaert I, Van Roy N, Van Goethem A, Van Maerken T, Zabrocki P, Cools J, Schulte JH, Vialard J, Speleman F, De Preter K.

Clin Cancer Res. 2015 Jul 15;21(14):3327-39. doi: 10.1158/1078-0432.CCR-14-2024. Epub 2015 Mar 24.

9.

Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma.

Rihani A, Van Goethem A, Ongenaert M, De Brouwer S, Volders PJ, Agarwal S, De Preter K, Mestdagh P, Shohet J, Speleman F, Vandesompele J, Van Maerken T.

Sci Rep. 2015 Mar 12;5:9027. doi: 10.1038/srep09027.

10.

miRBase Tracker: keeping track of microRNA annotation changes.

Van Peer G, Lefever S, Anckaert J, Beckers A, Rihani A, Van Goethem A, Volders PJ, Zeka F, Ongenaert M, Mestdagh P, Vandesompele J.

Database (Oxford). 2014 Aug 25;2014. pii: bau080. doi: 10.1093/database/bau080. Print 2014.

11.

The role of reflection in the effects of community service on adolescent development: a meta-analysis.

van Goethem A, van Hoof A, Orobio de Castro B, Van Aken M, Hart D.

Child Dev. 2014 Nov-Dec;85(6):2114-30. doi: 10.1111/cdev.12274. Epub 2014 Jul 24. Review.

PMID:
25056762
12.

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer.

Van Maerken T, Rihani A, Van Goethem A, De Paepe A, Speleman F, Vandesompele J.

Cancer Lett. 2014 Mar 28;344(2):157-65. doi: 10.1016/j.canlet.2013.11.002. Epub 2013 Nov 18. Review.

PMID:
24262662
13.

Peripheral neuropathy caused by joint-related cysts: a review of 17 cases.

Weyns F, Bringmans T, Vandevenne J, Daenekindt T, Van Goethem A, Wuyts J, Vanormelingen L, Vandersteen M.

Acta Neurochir (Wien). 2012 Oct;154(10):1741-53. doi: 10.1007/s00701-012-1444-8. Epub 2012 Sep 3.

PMID:
22941422
14.

The role of adolescents' morality and identity in volunteering. Age and gender differences in a process model.

van Goethem AA, van Hoof A, van Aken MA, Raaijmakers QA, Boom J, de Castro BO.

J Adolesc. 2012 Jun;35(3):509-20. doi: 10.1016/j.adolescence.2011.08.012. Epub 2011 Sep 23.

PMID:
21944561
15.

Randomised controlled trial comparing sapheno-femoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anaesthesia: one year results.

Pronk P, Gauw SA, Mooij MC, Gaastra MT, Lawson JA, van Goethem AR, van Vlijmen-van Keulen CJ.

Eur J Vasc Endovasc Surg. 2010 Nov;40(5):649-56. doi: 10.1016/j.ejvs.2010.08.007.

16.

Explicit- and implicit bullying attitudes in relation to bullying behavior.

van Goethem AA, Scholte RH, Wiers RW.

J Abnorm Child Psychol. 2010 Aug;38(6):829-42. doi: 10.1007/s10802-010-9405-2.

PMID:
20352324
17.

Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot.

van der Vange N, van Goethem AR, Zoetmulder FA, Kaag MM, van de Vaart PJ, ten Bokkel Huinink WW, Beijnen JH.

Eur J Surg Oncol. 2000 Nov;26(7):663-8.

PMID:
11078613
18.

Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines.

van de Vaart PJ, van der Vange N, Zoetmulder FA, van Goethem AR, van Tellingen O, ten Bokkel Huinink WW, Beijnen JH, Bartelink H, Begg AC.

Eur J Cancer. 1998 Jan;34(1):148-54.

PMID:
9624250
19.

Isobutyramide therapy in patients with sickle cell anemia.

Saleh AW Jr, van Goethem A, Jansen R, Velvis HJ, Gu LH, Huisman TH.

Am J Hematol. 1995 Jul;49(3):244-6.

PMID:
7541604

Supplemental Content

Loading ...
Support Center